Magnesium sulfate (MgSO4) is the most widely used therapy in the clinic to prevent the
progression of preeclampsia, a hypertensive disorder of pregnancy, to eclampsia …

Eclampsia is a hypertensive disorder of pregnancy that is defined by the new onset of grand
mal seizures on the basis of preeclampsia and a leading cause of maternal and fetal …

Objective: As maternal treatment with magnesium sulfate (MG) may protect the fetal brain,
we sought to assess the inflammation associated neuroprotective potential of MG and its …

Introduction Maternal inflammation may induce placental cytokine production resulting in
fetal exposure, and development of neonatal neurologic injury. Maternal magnesium …

Eclampsia, defined as unexplained seizure in a woman with preeclampsia, is a life-
threatening complication of pregnancy with unclear etiology. Magnesium sulfate (MgSO4) is …

OBJECTIVE: The purpose of this study was to investigate whether magnesium sulfate
(MgSO4) prevents fetal brain injury in inflammation-associated preterm birth (PTB). STUDY …

Previous studies have shown contradictory results regarding magnesium-mediated
neuroprotection in animal models of perinatal asphyxia. The aim of this study is to …

Abnormal placental inflammation has a role in the pathophysiology of preeclampsia.
Magnesium sulfate (MgSO 4) has anti-inflammatory properties and is a fetal neuroprotective …

Background: Maternal administration of magnesium sulfate (Mg) is used in humans to
protect the fetal brain during preterm delivery. We sought to determine the neuroprotective …

Abstract Objective: Antenatal magnesium sulfate (MgSO4) is recommended for fetal
neuroprotection. The aim of this animal study was to assess the neuroprotective effect of in …